The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective

F. Borgström, Å. Carlsson, H. Sintonen, S. Boonen, P. Haentjens, R. Burge, O. Johnell, B. Jönsson, J. A. Kanis

March 29 2006

F. Borgström - Å. Carlsson
Stockholm Health Economics,
Klarabergsgatan 33 3tr,
SE-111 21 Stockholm, Sweden

F. Borgström
Medical Management Centre, Karolinska Institutet,
Stockholm, Sweden

H. Sintonen
Department of Public Health, University of Helsinki,
Helsinki, Finland

S. Boonen
Leuven University Center for Metabolic Bone Diseases and
Division of Geriatric Medicine,
Katholieke Universiteit Leuven,
Leuven, Belgium

P. Haentjens
Department of Orthopaedics and Traumatology,
Academisch Ziekenhuis van de Vrije Universiteit Brussel,
Brussels, Belgium

R. Burge
Procter & Gamble Pharmaceuticals,
Mason, OH, USA

R. Burge
Division of Pharmaceutical Sciences, College of Pharmacy,
University of Cincinnati,
Cincinnati, OH, USA

O. Johnell
Department of Orthopaedics, Malmö General Hospital,
Stockholm, Sweden

B. Jönsson
Department of Economics, Stockholm School of Economics,
Stockholm, Sweden

J. A. Kanis
Centre for Metabolic Bone Diseases
(WHO Collaborating Centre),
University of Sheffield Medical School,
Sheffield, UK


Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

Discover the official journal of ESCEO on and read the journal contents on
You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.